Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraluminal Therapy for H. pylori Infection
NCT04853875Phase 4Completed
- Sponsor
- Mackay Memorial Hospital
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of tetracycline, metronidazole, bismuth subcitrate in Helicobacter pylori infection, sponsored by Mackay Memorial Hospital. Started Apr 2021; status: completed.
02
Drugs
tetracyclinemetronidazolebismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04853875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853875.